Antimuscarinic activity of oxybutynin in the human plasma quantitated by a radioreceptor assay. 1984

L Aaltonen, and H Allonen, and E Iisalo, and A Juhakoski, and T Kleimola, and R Sellman

The antimuscarinic activity of oxybutynin was measured as oxybutynin equivalents by a radioreceptor assay (RRA). The activity was studied in plasma samples of five volunteers after a single oral dose (10 mg) or after a single intravenous dose (28 micrograms/kg) of oxybutynin hydrochloride. The results were compared to the concentrations of the drug measured by gas liquid chromatography (GLC). Following oral administration, the maximum concentration measured by RRA was significantly higher (706 nmol/l) than that by GLC (38 nmol/l). In contrast, equal concentrations were measured after intravenous administration by both methods. Metabolites with antimuscarinic activity are possibly formed through first-pass metabolism after orally administered oxybutynin. The total antimuscarinic activity of oxybutynin and its metabolites are measured by RRA, but only the parent drug by GLC.

UI MeSH Term Description Entries
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008333 Mandelic Acids Analogs or derivatives of mandelic acid (alpha-hydroxybenzeneacetic acid). Acids, Mandelic
D011869 Radioligand Assay Quantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders). Protein-Binding Radioassay,Radioreceptor Assay,Assay, Radioligand,Assay, Radioreceptor,Assays, Radioligand,Assays, Radioreceptor,Protein Binding Radioassay,Protein-Binding Radioassays,Radioassay, Protein-Binding,Radioassays, Protein-Binding,Radioligand Assays,Radioreceptor Assays
D002849 Chromatography, Gas Fractionation of a vaporized sample as a consequence of partition between a mobile gaseous phase and a stationary phase held in a column. Two types are gas-solid chromatography, where the fixed phase is a solid, and gas-liquid, in which the stationary phase is a nonvolatile liquid supported on an inert solid matrix. Chromatography, Gas-Liquid,Gas Chromatography,Chromatographies, Gas,Chromatographies, Gas-Liquid,Chromatography, Gas Liquid,Gas Chromatographies,Gas-Liquid Chromatographies,Gas-Liquid Chromatography
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

L Aaltonen, and H Allonen, and E Iisalo, and A Juhakoski, and T Kleimola, and R Sellman
May 1987, Oral surgery, oral medicine, and oral pathology,
L Aaltonen, and H Allonen, and E Iisalo, and A Juhakoski, and T Kleimola, and R Sellman
January 1987, European journal of clinical pharmacology,
L Aaltonen, and H Allonen, and E Iisalo, and A Juhakoski, and T Kleimola, and R Sellman
January 1988, Journal of pharmaceutical and biomedical analysis,
L Aaltonen, and H Allonen, and E Iisalo, and A Juhakoski, and T Kleimola, and R Sellman
December 1987, Pharmaceutisch weekblad. Scientific edition,
L Aaltonen, and H Allonen, and E Iisalo, and A Juhakoski, and T Kleimola, and R Sellman
February 1991, Journal of pharmaceutical sciences,
L Aaltonen, and H Allonen, and E Iisalo, and A Juhakoski, and T Kleimola, and R Sellman
September 1982, The Journal of clinical endocrinology and metabolism,
L Aaltonen, and H Allonen, and E Iisalo, and A Juhakoski, and T Kleimola, and R Sellman
December 1985, Biochemical and biophysical research communications,
L Aaltonen, and H Allonen, and E Iisalo, and A Juhakoski, and T Kleimola, and R Sellman
May 1984, Pharmacological research communications,
L Aaltonen, and H Allonen, and E Iisalo, and A Juhakoski, and T Kleimola, and R Sellman
April 1982, Endocrinologia japonica,
L Aaltonen, and H Allonen, and E Iisalo, and A Juhakoski, and T Kleimola, and R Sellman
July 1976, Acta endocrinologica,
Copied contents to your clipboard!